Editorial: Microbiome in IBD: from Composition to Therapy.
Ruixin Zhu,Peijian He,Zhanju Liu,Ningning Liu,Yinglei Miao,Chenggong Yu,Lixin Zhu
DOI: https://doi.org/10.3389/fphar.2021.721992
IF: 5.6
2021-01-01
Frontiers in Pharmacology
Abstract:State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States, Center for IBD Research, Department of Gastroenterology, The Shanghai 10th People’s Hospital, Tongji University, Shanghai, China, Department of Gastroenterology, The Shanghai 10th People’s Hospital, Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai, China, Department of Gastroenterology, First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Diseases, Kunming, China, Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China, Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China